11-75241307-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001195528.2(TPBGL):āc.258C>Gā(p.Asp86Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000253 in 1,346,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001195528.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPBGL | NM_001195528.2 | c.258C>G | p.Asp86Glu | missense_variant | 1/1 | ENST00000562197.3 | NP_001182457.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPBGL | ENST00000562197.3 | c.258C>G | p.Asp86Glu | missense_variant | 1/1 | NM_001195528.2 | ENSP00000474988 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150392Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000268 AC: 32AN: 1195774Hom.: 0 Cov.: 30 AF XY: 0.0000291 AC XY: 17AN XY: 583652
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150392Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.258C>G (p.D86E) alteration is located in exon 1 (coding exon 1) of the TPBGL gene. This alteration results from a C to G substitution at nucleotide position 258, causing the aspartic acid (D) at amino acid position 86 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at